Casimersen for the treatment of Duchenne muscular dystrophy

Trends Pharmacol Sci. 2022 Jul;43(7):607-608. doi: 10.1016/j.tips.2022.04.009. Epub 2022 May 14.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Humans
  • Muscular Dystrophy, Duchenne* / drug therapy
  • Oligonucleotides

Substances

  • Oligonucleotides
  • casimersen